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Introduction
Widespread declines in stroke mor-
tality have been observed in the United
States since the early 1900s, with variation
in the magnitude and timing of declines
reported by race, sex, and age group.'4
Although the factors that have facilitated
these long-term declines have not been
identified, the recent declines in stroke
mortality are commonly thought to be pri-
marily a result of increased and improved
pharmacotherapy for hypertension.
Given the strength of the association be-
tween elevated blood pressure and
stroke,7 together with results of random-
ized clinical trials that provide evidence
for the efficacy of antihypertensive drugs
in reducing the risk of stroke,8,9 many
health care providers, researchers, and
policymakers operate under the assump-
tion that increased and improved pharma-
cotherapy for hypertension is the primary
determinant of the recent declines in
stroke mortality. The underlying hypoth-
esis, referred to in this study as the treat-
ment hypothesis, is that the greater the
increases in detection, treatment, and
control of hypertension, the larger the de-
cline in stroke mortality rates.
Despite clinical evidence that antihy-
pertensive drugs reduce the risk of stroke,
the impact of increased pharmacotherapy
for hypertension on the declines in stroke
mortality is debatable. Studies of popula-
tion attributable benefit estimated that the
proportion of decline in stroke mortality
attributable to increased pharmacological
treatment of hypertension was approxi-
mately 10% in New Zealand from 1973 to
1980, and approximately 12% in the United
States from 1970 to 1980.10,11 Another
study reported no association between the
rank ordering of changes in pharmacolog-
ical treatment of hypertension and changes
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in stroke mortality from 1973 to 1980
among eight race-, sex-, and age-specific
groups in the United States.12 Our study
expands upon previous studies by exam-
ining the association between temporal
trends in pharmacological control of hyper-
tension and declines in stroke mortality
among 96 groups stratified by race, sex,
age, metropolitan status, and region, while
considering the influences of hypertension
prevalence and socioeconomic profile.
Methods and Materials
Data on the prevalence and pharma-
cological control of hypertension, stroke
mortality rates, and socioeconomic pro-
files were obtained for the 96 population
subgroups formed by the cross tabulation
of the following variables: age (45-54, 55-
64, 65-74); race-sex (Black women, Black
men, White women, White men); metro-
politan status (metropolitan [to accommo-
date the different geographic units used for
the survey data vs the mortality data, met-
ropolitan status was defined as either a
standard metropolitan statistical area or
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any county that included a piece ofsuch an
area], nonmetropolitan); and region
(Northeast, Midwest, South, West; see
Appendix A for the list of states in each
region as defined by the National Center
forHealth Statistics). These 96 groups con-
stitute the units of analysis for this study.
Data on the prevalence of hyperten-
sion (proportion of people who have dia-
stolic blood pressure of at least 95 mm Hg
and/or are currently using antihyperten-
sive medication), controlled hypertension
(proportion of hypertensives who re-
ported receiving antihypertensive medica-
tion and also had controlled diastolic
blood pressure levels below 95 mm Hg),
and treated hypertension (proportion of
hypertensives who reported receiving an-
tihypertensive medication) were obtained
from the following national health sur-
veys: National Health and Examination
Survey 1960-1962 (NHES), National
Health and Nutrition Examination Survey
I 1971-1974 (NHANES I), and National
Health and Nutrition Examination Survey
II 1976-1980 (NHANES II). In the inter-
est of using comparable blood pressure
measurements over the three surveys, hy-
pertensionwas determined bythe value of
the first blood pressure measurement at
time of exaMination.13
Each surveywas acomnplexmultistage
sample survey designed to assess the health
status of the civflian noninstitutionalized
adult population in the United States. Par-
ticipants between the ages of45 and 74who
were both interviewed and examined are
included in this study (NHES: n = 2650;
NHANES I: n = 6277; NHANES II:
n = 6522). The appropriate sample weights
were used with SESUDAAN14 to estimate
epresentativeproportionsforeachofthe 96
sociodemographic groups in this study.
Stein's estimator was applied to adjust for
less stable estimates, whichcould otherwise
distort the distnbution, and to reduce re-
gression to the mean of the estimated pro-
portions across the three national health
SuVeys.15-17 Stein's esimator shrinks each
estimated proportion toward the center of
the distnbution in a manner that is inversely
associatedwith the standard deviationofthe
esimated prportion (see Appendix B).
For each group, the following indica-
tors of socioeconomic profile were ob-
tained from the national health surveys in
the same manner described above: edu-
cation profile (the percentage of people
who received a high school education or
more); income profile (the percentage of
peoplewith an annual income greater than
$10 000); occupation profile (the percent-
age of people employed in white-collar
occupations-i.e., professional, techni-
cal, and kindred workers; managerial,
clerical sales, and kindred workers). Pre-
vious studies suggest that the availability
ofeconomic and social resources, as mea-
suredbycensus dataofthese indicators, is
associated with patterns of cardiovascular
disease mortality.18-21
Annual numbers of stroke deaths,
based on the underlying cause of death,
were obtained from the National Center for
Health Statistics. Population counts were
obtained from the US Bureau of the Cen-
sus. Diectly age-adjusted stroke mortality
rates were calculated for each sociodemo-
graphic group (within 10-year age bands)
by grouping the stroke deaths (Internation-
al Classrifation ofDiseases codes 330 to
334 for the seventh revision, codes 430 to
438 for the eighth and ninth revisions) and
population counts into groups stratified by
age, race, sex, metropolitan status, and re-
gion. The 1970 population was used as the
standard.
The average annual absolute change
in prevalence of controlled hypertension
was calculated by dividing the magnitude
of change from one survey to the next by
the number of years that had passed from
the midpoint of the first survey to the mid-
point of the next survey. This method was
also used to calculate change in prevalence
of treated hypertension and in socioeco-
nomic profile. The average annual percent
change in stroke mortality was estimated
with a piecewise log linear regression mod-
el22for the time periods 1962 to 1972 and
1973 to 1980.
We divided the period ofobservation
into two (1962-1972, 1973-1980) for the
following reasons: (1) stroke mortality
trends among many of the sociodemo-
graphic groups in this study suggest that
declines in stroke mortality accelerated
roughly around 1972,2-4and (2) the timing
ofthe national health examination surveys
corresponds with the two time periods.
Population weighted linear regres-
sion was used to estimate the association
between change in stroke mortality and
change in the prevalence of controlled hy-
pertension while adjusting for the preva-
lence of hypertension. The prevalence of
hypertension was included in the model
because it is an integral component of the
exposure. The potential impact of a small
increase in the proportion of hyperten-
sives with controlled hypertension will be
much larger in a group with a high prev-
alence of hypertension compared with a
group with a low prevalence of hyperten-
sion because a larger proportion of the
population will have become exposed to
antihypertensive treatment. Additional
analyses were performed to (1) determine
the association of trends in the prevalence
of treated but uncontrolled hypertension
with declines in stroke mortality, (2) as-
sess effect modification of the treatment
hypothesis by category of hypertension
prevalence, and (3) examine the associa-
tion between socioeconomic profile and
declines in stroke mortality.
Resmlts
Larger changes in both stroke mortal-
ity and controlled hypertension oured
during the post-1972 years than during the
pre-1972 years (Table 1). From 1973 to
1980, the average annual percent change in
stroke mortality was -6.5% per year com-
pared with -1.6% in the pre-1972 years.
The average annual absolute change in
prevalence of controlled hypertension was
2.0%o during the post-1972 years compared
with -0.4% in the earlier period.
The shifts in the distributions of both
variables are shown in Figure 1. Each
point on the scatterplot represents one of
the 96 population subgroups. The values
for the time period 1962 to 1972 are
marked with Xs; those for 1973 to 1980 are
marked with squares. Given the favorable
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shifts in the distnbutions of change in both
controlled hypertension and stroke mor-
tality, the pattern for the entire period
(1962 to 1980) suggests that there was an
association between trends in controlled
hypertension and declines in stroke mor-
tality. However, within each of the spec-
ified time periods, the scatterplot suggests
that there was virtually no association.
Regression results quantify the ob-
servations noted in the scatterplot while
adjusting for the prevalence of hyperten-
sion (Table 2). An association in favor of
the treatment hypothesis is observed
when the periods 1962 to 1972 and 1973 to
1980 are combined together as a single pe-
riod (model 1, Table 2). The beta coeffi-
cient, -0.68, indicates that for every addi-
tional percent increase in the prevalence
of controlled hypertension, the average
annual rate of decline in stroke mortality
increased by 0.68%. However, when time
period was included in the model, it ac-
counted for most of the previously ob-
served association (model 2, Table 2).
This implies that the overall association
from 1962 to 1980was confounded by time
period (which may represent a number of
factors). Therefore, the remainder of the
study results are stratified by time period.
During the pre-1972 period, therewas
virtually no association between the
trends in controlled hypertension and the
declines in stroke mortality among the 96
sociodemographic groups (1 = 0.04,
P = .69; Table 2). During the post-1972
years, the groups with the largest in-
creases in the prevalence ofcontrolled hy-
pertension experienced slightly slower
rates of decline in stroke mortality
(1 = 0.16,P = .003).Thisbetacoefficient
for the later period indicates that, for ev-
ery additional percent increase in the
prevalence of controlled hypertension,
the average annual rate of decline in stroke
mortality slowed by 0.16%. During both
the pre- and post-1972 years, the groups
with the higher prevalence of hyperten-
sion at the beginning of the period expe-
rienced the larger declines in stroke mor-
tality (1 = -0.06 and -0.05 for each time
period, respectively) (Table 2).
The magnitude of acceleration in
stroke declines from the pre-1972 period
to the post-1972 period (measured as the
difference between the rate of decline in
the two periods) was regressed upon the
change in controlled hypertension from
NHES to NHANES II. The results indi-
cate that groups with the larger accelera-
tion in stroke mortality declines did not
show larger changes in controlled hyper-
tension ( = 0.03, P = .04).
Examination of the association be-
tween trends in prevalence of treated hy-
pertension (regardless of blood pressure
control) and declines in stroke mortality
(Table 3) produced results very similar to
those presented for trends in controlled hy-
pertension. Because control of hyperten-
sion should have a larger impact on the risk
of stroke than should treatment per se, the
remainder of this study focuses on the as-
sociation between trends in controlled hy-
pertension and declines in stroke mortality.
A suggestion of effect modification
by prevalence ofhypertension is observed
in Table 4. Within each time period, the
beta coefficient in favor of the treatment
hypothesis occurs only among the groups
in the highest tertile.
The association between trends in
socioeconomic profile and declines in
stroke mortality varied by time period
(Table 5). In the first period (1962 to
1972), groups with the largest increases in
education and income profiles experi-
enced the slowest rates of decline in
stroke mortality (i.e., a 1% increase in the
proportion of high school graduates and
families with annual incomes above
$10 000 was associated with a slowing in
the average annual rate of decline in
stroke mortality of 0.30% and 0.24%, re-
spectively). In the second period (1973 to
1980), the pattern was reversed. Groups
with the largest increases in all three
components of socioeconomic profile ex-
perienced modestly yet consistently
faster rates of decline in stroke mortality
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( = -0.11, -0.03, and -0.04 for educa-
tion, income, and occupation profiles, re-
spectively).
Diwcussion
The widespread declines in stroke
mortality among many sociodemographic
groups in the United States suggest that
equallywidespread changes have occurred
in population-level conditions that influ-
ence the occurrence of stroke deaths. In-
vestigation of the association between
changes in population-level conditions and
dedines in stroke mortality requires an ag-
gregate-level study with a group-rather
than an individual-as the unit of analysis.
Although aggregate-level studies are pop-
ularly used to make inferences about asso-
ciations at the individual level,23'24 the re-
sults of this study pertain specifically to
population-level associations and are not
meant to be interpreted as proxies for in-
dividual-level associations.25,26
The results of this study contribute to
a growing body of literature that suggests
that, although phannacological treatment
of hypertension may have contributed to
the declines in stroke mortality, it may not
have been the primaiy determinant be-
tween 1962 and 1980.10-12 Within the two
time periods examined (1962 to 1972 and
1973 to 1980), groups with the largest in-
creases in treatment and control of hyper-
tension did not experience the largest de-
clines in stroke mortality. In the pre-1972
period, there was virtualy no association
between increases in the prevalence of
controlled hypertension and declines in
stroke mortality among the 96 sociodemo-
graphic groups, while in the post-1972 pe-
riod, the data suggest that groups with
larger increases in controlled hypertension
had slightly slower declines in stroke mor-
tality.
When the data are stratified by prev-
alence of hypertension, there is some ev-
idence in favor of the treatment hypothe-
sis among groups with the highest
prevalence ofhypertension. Relationships
in groups with lower prevalence are not
consistent with the treatment hypothesis.
This is noteworthy because groups with
higher prevalences of hypertension are
more likely to benefit from antihyperten-
sive treatment programs.
The discrepancy in the results ob-
tained when examining the association
over the entire period as opposed to the
association within each time period can be
attributed to the major shifts in the distri-
butions of trends in both stroke mortality
and controlled hypertension. The most
likely candidate for explaining the shift in
controlled hypertension is the establish-
ment in 1972 of the National High Blood
Pressure Education Program, a govem-
ment-sponsored coalition of private and
public agencies worling to increase the de-
tection, treatment, and control of hyper-
tension in the United States. There is little
doubt that the efforts of this program have
contributed to improved pharmacological
management of hypertension. However, if
increased pharmacological control of hy-
pertension is to be considered the prmnaiy
determinant ofdeclines in stroke mortality,
as much ofthe literature claims, the lack of
association between trends in controlled
hypertension and declines in stroke mor-
talitywithin each time period remains to be
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explained, as does the lack of association
between accelerated stroke mortality de-
clines and increased controlled hyperten-
sion.
The smaller amount of variability in
the distributions ofchangingprevalence of
controlled hypertension and stroke mor-
tality within each period vs the combined
periods could make it more difficult to de-
tect an association within each period. In
addition, the instability ofproportions and
rates due to small numbers amongsome of
the 96 sociodemographic groups could re-
strict the ability to detect an association.
Other potential sources of error in this
study include nonresponse bias for the
variables obtained from the national
health surveys27 and variation in the ac-
curacyofstroke mortality diagnosis due to
use ofdeath certificate data.28-30Although
these factors are not likely to occur ran-
domly, there is not enough information to
speculate upon the direction of potential
bias.
The lack of available data on the se-
verity ofhypertension at the onset ofphar-
macological treatment may also hamper
the ability to evaluate fully the treatment
hypothesis. The magnitude ofreduction in
absolute risk is greater among severe hy-
pertensives than among mild and moder-
ate hypertensives.31 Therefore, according
to the treatment hypothesis, groups with
largerproportions ofsevere hypertensives
at the onset oftreatment may be expected
to have larger declines in stroke mortality.
Alternatively, groups with larger preva-
lences of severe hypertension among the
nontreated hypertensives may have
slower stroke mortality declines even if
they have large proportions of hyperten-
sives with controlled hypertension.
Inclusion of data on trends in ciga-
rette smoking would also improve the
evaluation of the treatment hypothesis
and our understanding of the trends in
stroke mortality.32-34 Although, during the
earlier period ofobservation in this study,
the prevalence of smoking among some
sociodemographic groups was increasing
while stroke mortality rates were decreas-
ing, the recent declines in smoking among
several sociodemographic groups35-38
may have contributed to the declines in
stroke mortality for those groups. Unfor-
tunately, comparable data on smoking
trends were not available for the 96 socio-
demographic groups in this study.
Alternative explanations for the lack
of evidence in favor of the treatment hy-
pothesis deal with the historical context
within which the antihypertensive pro-
gramswere introduced and the differential
outreach of such programs among the so-
ciodemographic groups included in this
study. Declines in stroke mortality among
both Blacks and Whites were occurring
decades prior to the introduction of anti-
hypertensive treatment.1-4 Therefore, fac-
tors that contributed to the long-term de-
clines in stroke mortality may have had a
stronger impact on the recent trends in
stroke mortality than did the recent in-
creases in pharmacological treatment of
hypertension. This seems especially plau-
sible given patterns ofchange in controlled
hypertension and stroke mortality among
sociodemographic groups. For instance,
from 1973 to 1980, White men and Black
women experienced the fastest average
annual rate of decline in stroke mortality
(7.7% for Black women and 7.0% for
White men, compared with 6.1% and
6.3% for White women and Black men,
respectively). White men achieved these
large declines in stroke mortality with an
average annual increase of only 1.1% in
the prevalence of controlled hyperten-
sion, whereas the increase for Black
women was 4.5%-four times larger than
that of White men. Consequently, other
factorsmayoperate at the population level
that either add to or detract from the ef-
fectiveness of increased antihypertensive
pharmacotherapy on declines in stroke
mortality or that influence the rates of
stroke mortality directly.
Modest associations of the temporal
trends in socioeconomic profile with the
declining stroke mortality rates were ob-
served from 1973 to 1980. Larger associa-
tionswere observed (but not presented) be-
tween the level of stroke mortality and
indicators of socioeconomic profile, as has
been reported in other studies.21,39-41
These results lend further support to the
view that socioeconomic conditions define
the context within which the distributions
ofphysiological and behavioral risk factors
are determined.42-4 Further studies are
needed to examine the distributions of
identified risk factors for essential hyper-
tension45"46 (i.e., diet, physical activity,
psychosocial stressors) by socioeconomic
indicators, and to better elucidate the
mechanisms that link environmental stim-
uli to physiological responses associated
with hypertension andwith stroke directly.
The implications of the results from
this study neither address nor challenge
the efficacy of antihypertensive drugs to
reduce the risk of stroke among individu-
als under conditions of clinical and com-
munity trials. Instead, the results are per-
tinent to an understanding ofthe impact of
the high-risk intervention strategy on the
declining stroke mortality rates from a
public health perspective. It appears that,
among the sociodemographic groups in
this study, the mass treatment approach is
not the principal determinant of the de-
clines in stroke mortality. This does not
imply that clinicians should not treat hy-
pertensives with antihypertensive agents,
but, from a public health perspective, it
does support the idea that we cannot rely
on mass treatment of hypertension to
bring about the greatest declines in stroke
mortality. Further support for this conclu-
sion comes from the fact that the largest
population attributable risk for all cause
mortalityoccurs in the high normal to mild
hypertension range of the blood pressure
distribution.47 While this group contrb-
utes the most to excess mortality rates, it
benefits the least from the high-risk/mass
treatment approach.
Although the notion was once con-
sidered a heresy, it is nowwidely accepted
that environmental improvements in san-
itation, nutrition, and housing had a larger
impact on past declines in infectious dis-
ease mortality than did specific medical
measures.48 The present results, as well as
evidence of long-term declines in stroke
mortality prior to the development and
widespread dissemination of antihyper-
tensive drugs, suggest a more contempo-
rary version of this old debate about the
determinants of changes in mass disease.
It is, of course, in keeping with basic pub-
lic health tenets that environmental
changes affecting entire populations are
likely to have a greater impact than inter-
ventions that target individuals one at a
time and depend on access and compli-
ance for their success.49
From a public health perspective,
further attention should be given to un-
derstanding the role of secular trends in
other characteristics-e.g., educational
resources, dietary pattems, occupational
opportunities, cigarette smoking, and liv-
ing conditions-that may have influenced
the declines in stroke mortality. A better
understanding ofthe combinations ofcon-
ditions that have facilitated the declines in
stroke mortality is important for planning
the most effective intervention strategies
to further reduce the levels of stroke mor-
tality among all sociodemographic groups
in the United States. O
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